Such antiproliferative effect of exendin-4 on prostate cancer was not via androgen receptor, but through the inhibition of extracellular signal–regulated kinase-mitogen-activated protein kinase (ERK-MAPK) phosphorylation via GLP-1R [26]. The gene discussed is AR; the disease is prostate carcinoma.